Fanny Cavalie, Chief Strategy/Bus Operations Officer at Foghorn Therapeutics Inc. (FHTX), sold 11,000 shares at $6.56 ($72K) on 2024-03-11, disclosed to the SEC on 2024-03-12.
Open-market sale of $72k FHTX by Chief Strategy/Bus Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.